Rhenman & Partners Asset Management AB as of June 30, 2018
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 89 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nektar Therapeutics | 3.1 | $30M | 618k | 48.83 | |
| Horizon Pharma | 2.8 | $27M | 1.6M | 16.56 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $26M | 155k | 169.96 | |
| Incyte Corporation (INCY) | 2.6 | $26M | 384k | 67.00 | |
| Abiomed | 2.5 | $25M | 60k | 409.06 | |
| Bristol Myers Squibb (BMY) | 2.5 | $24M | 440k | 55.34 | |
| CVS Caremark Corporation (CVS) | 2.5 | $24M | 374k | 64.35 | |
| Medtronic (MDT) | 2.5 | $24M | 280k | 85.61 | |
| Alexion Pharmaceuticals | 2.4 | $24M | 192k | 124.15 | |
| UnitedHealth (UNH) | 2.4 | $24M | 96k | 245.34 | |
| Express Scripts Holding | 2.3 | $23M | 295k | 77.21 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $23M | 240k | 94.20 | |
| CIGNA Corporation | 2.3 | $22M | 130k | 169.95 | |
| Jazz Pharmaceuticals (JAZZ) | 2.3 | $22M | 128k | 172.30 | |
| Humana (HUM) | 2.2 | $22M | 73k | 297.63 | |
| Loxo Oncology | 2.2 | $21M | 123k | 173.48 | |
| Allergan | 2.1 | $21M | 125k | 166.72 | |
| Becton, Dickinson and (BDX) | 2.1 | $20M | 85k | 239.56 | |
| Sage Therapeutics (SAGE) | 2.1 | $20M | 130k | 156.53 | |
| Exelixis (EXEL) | 2.1 | $20M | 941k | 21.52 | |
| Walgreen Boots Alliance | 2.0 | $20M | 330k | 60.02 | |
| Gilead Sciences (GILD) | 1.9 | $19M | 262k | 70.84 | |
| Anthem (ELV) | 1.9 | $18M | 76k | 238.03 | |
| Eli Lilly & Co. (LLY) | 1.8 | $17M | 200k | 85.33 | |
| Celgene Corporation | 1.7 | $17M | 211k | 79.42 | |
| Esperion Therapeutics (ESPR) | 1.6 | $16M | 406k | 39.19 | |
| Seattle Genetics | 1.6 | $15M | 230k | 66.39 | |
| Sangamo Biosciences (SGMO) | 1.5 | $15M | 1.1M | 14.20 | |
| Fibrogen | 1.5 | $15M | 240k | 62.60 | |
| Spark Therapeutics | 1.5 | $15M | 178k | 82.76 | |
| Glaukos (GKOS) | 1.5 | $15M | 360k | 40.64 | |
| Novocure Ltd ord (NVCR) | 1.4 | $14M | 450k | 31.30 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $14M | 160k | 84.23 | |
| Portola Pharmaceuticals | 1.4 | $13M | 352k | 37.77 | |
| Abbott Laboratories (ABT) | 1.3 | $13M | 212k | 60.99 | |
| Aetna | 1.3 | $13M | 70k | 183.50 | |
| Arena Pharmaceuticals | 1.3 | $12M | 285k | 43.60 | |
| Intra Cellular Therapies (ITCI) | 1.3 | $12M | 697k | 17.67 | |
| Array BioPharma | 1.2 | $12M | 723k | 16.78 | |
| Alkermes (ALKS) | 1.2 | $12M | 290k | 41.16 | |
| Boston Scientific Corporation (BSX) | 1.2 | $11M | 348k | 32.70 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $11M | 114k | 98.49 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $11M | 110k | 98.24 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $11M | 848k | 12.80 | |
| Immunomedics | 1.1 | $11M | 455k | 23.67 | |
| AmerisourceBergen (COR) | 1.1 | $11M | 124k | 85.27 | |
| Edwards Lifesciences (EW) | 1.0 | $10M | 68k | 145.57 | |
| Myokardia | 1.0 | $9.8M | 198k | 49.65 | |
| Flexion Therapeutics | 0.9 | $9.1M | 352k | 25.85 | |
| Adamas Pharmaceuticals | 0.9 | $8.5M | 328k | 25.83 | |
| Livanova Plc Ord (LIVN) | 0.9 | $8.5M | 85k | 99.82 | |
| Centene Corporation (CNC) | 0.8 | $8.0M | 65k | 123.22 | |
| Xencor (XNCR) | 0.8 | $8.0M | 216k | 37.01 | |
| Johnson & Johnson (JNJ) | 0.8 | $7.3M | 60k | 121.33 | |
| Macrogenics (MGNX) | 0.7 | $6.7M | 325k | 20.65 | |
| Abbvie (ABBV) | 0.7 | $6.5M | 70k | 92.66 | |
| Regeneron Pharmaceuticals (REGN) | 0.6 | $5.9M | 17k | 345.00 | |
| Omnicell (OMCL) | 0.6 | $5.8M | 110k | 52.45 | |
| Revance Therapeutics | 0.6 | $5.6M | 203k | 27.45 | |
| Coherus Biosciences (CHRS) | 0.5 | $4.9M | 350k | 14.00 | |
| Rigel Pharmaceuticals | 0.5 | $4.8M | 1.7M | 2.83 | |
| Aerie Pharmaceuticals | 0.5 | $4.7M | 70k | 67.56 | |
| Medicines Company | 0.4 | $4.0M | 110k | 36.70 | |
| Biogen Idec (BIIB) | 0.4 | $3.8M | 13k | 290.23 | |
| Diplomat Pharmacy | 0.4 | $3.6M | 142k | 25.56 | |
| Viewray (VRAYQ) | 0.4 | $3.6M | 517k | 6.92 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $3.4M | 220k | 15.27 | |
| Zogenix | 0.2 | $2.2M | 50k | 44.20 | |
| Achillion Pharmaceuticals | 0.2 | $1.7M | 618k | 2.83 | |
| Chimerix (CMRX) | 0.2 | $1.6M | 342k | 4.76 | |
| Pieris Pharmaceuticals | 0.2 | $1.5M | 300k | 5.07 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $907k | 428k | 2.12 | |
| Adverum Biotechnologies | 0.1 | $816k | 154k | 5.30 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $563k | 6.8k | 82.75 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $441k | 4.2k | 104.13 | |
| Chevron Corporation (CVX) | 0.1 | $472k | 3.7k | 126.44 | |
| Walt Disney Company (DIS) | 0.0 | $365k | 3.5k | 104.79 | |
| Halliburton Company (HAL) | 0.0 | $415k | 9.2k | 45.01 | |
| International Business Machines (IBM) | 0.0 | $344k | 2.5k | 139.78 | |
| Qualcomm (QCOM) | 0.0 | $407k | 7.2k | 56.16 | |
| Ford Motor Company (F) | 0.0 | $359k | 32k | 11.08 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $382k | 3.8k | 100.84 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $363k | 12k | 30.69 | |
| Microsoft Corporation (MSFT) | 0.0 | $285k | 2.9k | 98.72 | |
| Pfizer (PFE) | 0.0 | $318k | 8.8k | 36.33 | |
| Wells Fargo & Company (WFC) | 0.0 | $325k | 5.9k | 55.48 | |
| Symantec Corporation | 0.0 | $261k | 13k | 20.66 | |
| Regulus Therapeutics | 0.0 | $325k | 493k | 0.66 | |
| Alphabet Inc Class A cs (GOOGL) | 0.0 | $201k | 178.00 | 1129.21 |
